A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial.
Koenraad H BlotLuc DuchateauBenedicte LescrauwaetNilani LiyanageDavid RayBeloo MirakhurAaron I VinikPublished in: Patient related outcome measures (2019)
ClinicalTrials.gov identifier: NCT00774930.